NMC Health welcomes Tarek Alnabulsi to its Board as Independent Director

– UAE, Abu_Dhabi – NMC Health plc (LON:NMC), the leading private healthcare operator in the Gulf Cooperation Council with international services across 19 countries, today announced the appointment of Tarek Alnabulsi as an Independent Non-Executive Director of the Company. Mr Alnabulsi’s appointment is effective from 5 April 2019.

Tarek Alnabulsi was appointed by the Board following a search undertaken by an external recruitment consultancy. The search, overseen by the Nominations Committee on the Board’s behalf, specifically focused on bringing additional expertise from the Kingdom of Saudi Arabia to the NMC Health plc Board given the Company’s expansion plans into the Kingdom.

Mark Tompkins, Joint Non-Executive Chairman of NMC Health commented: ‘We welcome Tarek Alnabulsi to the NMC Health plc Board. As part of our search requirements, the Nominations Committee focussed on expertise and experience of Saudi Arabia as a key criteria for our search given the Company’s expansion plans into the Kingdom. We are delighted that Tarek has agreed to join our Board and we look forward to his guidance as part of our future strategic decisions.”

About Tarek Alnabulsi

Tarek Alnabulsi is an entrepreneur who has founded and co-founded a number of businesses in Saudi Arabia, UAE and USA having had more than 20 years of Executive roles with leading and diversified Groups in the Middle East. He is also an adviser to family businesses on governance, investments and business strategies.

Previously, Mr Alnabulsi was a Non-Executive Director and Chairman of the Audit committee of United Assurance Company, a leading insurance company listed on Tadawul in Saudi Arabia, and on the Board of a number of other prominent companies in Saudi Arabia and UAE, including Injazat Technology Fund, Ebayanat and Arabian Entertainment Company.

About NMC Health

NMC the leading private healthcare operator in the GCC with an international network of hospitals across 19 countries. NMC also ranks as one of the top three in-vitro fertilisation operators globally. The Group is also a leading provider of long-term medical care in the UAE through its subsidiary ProVita. Pursing an aggressive international expansion program from 2016, NMC has identified the Kingdom of Saudi Arabia in particular as a key growth market, where the company has introduced long-term and multi-specialty care services. NMC received over 7.5m patients in 2018. The Group is also a leading UAE supplier of products and consumables across several key market segments, with the major contribution coming from healthcare related products. The Group reported revenues of US$2.1 billion for the year ended 31 December 2018.

In April 2012 NMC was listed on the Premium Segment of the London Stock Exchange. NMC is a constituent of the FTSE 100 Index.

For more information : https://nmc.ae

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.